ArticleDermatology and therapy2026

Efficacy and Safety of Benvitimod Compared with Halometasone in Patients with Moderate-to-Severe Chronic Hand Eczema: A Prospective, Single-Center, Parallel-Group, Open-Label Randomized Trial.

Yuan Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.